The European Medicines Agency’s EMA) human medicines committee (CHMP) recommended four novel medicines for approval at its ...

A new analysis from DelveInsight shows that NF-κB inhibitors are edging closer to the clinic, with drug candidates in ...

South Korean firm Celltrion today showcased its longstanding commitment to expanding its biosimilar portfolio in the field of ...

The American medicines regulator has ended a barren stretch in hereditary angioedema with three approvals in 2025, according ...

Japanese drugmaker Astellas has received conditional approval of Izervay (avacincaptad pegol intravitreal solution: ACP) for ...

Japanese pharma major Shionogi announced that its subsidiary Torii Pharmaceutical has received manufacturing and marketing ...

Advisory Committee on Immunization Practices (ACIP) met on Thursday, with a host of newly-appointed members among its number.

Switzerland-based Idorsia announced that the medicines regulator Swissmedic has granted marketing authorization for Jeraygo ...

Receive The Pharma Letter daily news bulletin, free forever. Unfettered access to industry-leading news, commentary and analysis in pharma and biotech. Updates from clinical trials, conferences, M&A, ...

Continuing the upmanship battle in expanding the use of GLP-1 drugs beyond diabetes and obesity, Novo Nordisk has released ...

US biotech Replimune (Nasdaq: REPL) said a meeting with the American medicines regulator has not yet resolved questions ...

Swedish Orphan Biovitrum, known as Sobi, and Ionis Pharmaceuticals announced that Tryngolza (olezarsen) has been approved in ...